Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00314275
Status:
COMPLETED
Last Update Posted:
2012-04-20
First Post:
2006-04-11
Brief Title:
The ENDEAVOR Pharmacokinetic PK Registry The Medtronic Endeavor Drug Eluting Coronary Stent System
Sponsor:
Medtronic Vascular
Organization:
Medtronic Vascular
Study Overview
Official Title:
Evaluation of Pharmacokinetics PK and Safety of the Medtronic Endeavor Drug ABT-578 Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ENDEAVOR PK
Brief Summary:
The purpose of this study is to evaluate the pharmacokinetics PK and safety associated with ABT-578 administered using the Medtronic Endeavor Drug Eluting Coronary Stent system in the treatment of single de novo lesions in native coronary arteries between 25 - 35 mm in diameter
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None